Work

Frequent, moderate-dose cyclophosphamide administration improves the efficacy of cytochrome P-450/cytochrome P-450 reductase-based cancer gene therapy.

Year: 2001

Type: article

Source: PubMed

Authors: Y Jounaidi, D J Waxman

Institution: Boston University

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: Combination Therapies for Cancer Treatment

OpenAlex ID: W2100227988

FWCI: 2.601

Cites: 33

Cited by: 52

Related to: 10